Filing Flows

Filing Flows › Vaxart (VXRT) › Next earnings date

Vaxart (VXRT) earnings: beat the estimate

Vaxart (VXRT) reported on Nov 5, 2026 and beat the EPS estimate: −$0.07 against −$0.31 (+77.4%). Revenue was $10.6M for Q3 2026, -85% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+77.4% vs estimate
Beat rate80%

The last report

Vaxart reported revenue of $10.6M for the third quarter 2026 (-85% Y/Y), net loss $17.7M: Government Contract $7.5M, Collaboration Revenue $2.9M, Non Cash Royalty Revenue $154K. How it makes money → · Every quarter →

Vaxart: EPS against the estimate, last 5 reportsVaxart: EPS against the estimate, last 5 reportsEstimateReported−$0.07−$0.04Nov 25−$0.08$0.24Mar 26$0.02$0.02May 26−$0.21−$0.06Aug 26−$0.31−$0.07Nov 26
Latest (Nov 26): Estimate −$0.31, Reported −$0.07.

Vaxart's latest quarter

Vaxart, Q3 2026: revenue $10.6M (-85% year over year), operating margin -162.7%, net loss $17.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.

Questions

Did Vaxart beat earnings?

Vaxart (VXRT) reported on Nov 5, 2026 and beat the EPS estimate: −$0.07 against −$0.31 (+77.4%).

When does VXRT report earnings?

The next date is not set yet.

Does Vaxart usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.